EPISODE · Jan 5, 2026 · 11 MIN
Tesamorelin from bench to bedside FDA approval
from Today's discussion on unraveling BPC 157 Peptide
This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.Topics include:Tesamorelin peptide mechanism of actionPreclinical and animal studiesPhase II and Phase III clinical trial dataFDA approval and HIV-associated lipodystrophyGrowth hormone, IGF-1, and metabolic effectsSafety, limitations, and ongoing research
NOW PLAYING
Tesamorelin from bench to bedside FDA approval
No transcript for this episode yet
Similar Episodes
Apr 22, 2025 ·32m
Feb 27, 2025 ·0m
Sep 20, 2024 ·57m
Aug 7, 2024 ·16m